European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma-Reference-Cited by-同舟云学术

European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma

Published:2002-08 Issue:4 Volume:29 Page:382-388
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Eggermont Alexander M.M.,Gore Martin

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference52 articles.

1. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm;Veronesi;N Engl J Med,1988

2. Update WHO-10 trial;Cascinelli,1995

3. Wide versus narrow surgical excision in thin (<2 mm) stage I primary cutaneous malignant melanoma: Long term results of a French multicentric prospective randomized trial on 319 patients;Banzet;Proc Am Assoc Clin Oncol,1993

4. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm;Cohn-Cedermark;Cancer,2000

5. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial;Balch;Ann Surg,1993

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment;Melanoma Research;2010-06

2. Cutaneous Malignant Melanoma;Managing Skin Cancer;2010

3. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells;International Journal of Cancer;2009-03-15

4. Detection of melanoma micrometastases in sentinel nodes – The cons;Surgical Oncology;2008-09

5. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial;The Lancet;2008-07